Exploring the sequence identity of cytoplasmic chromatin in senescence
Exploring the sequence identity of cytoplasmic chromatin in senescence
批准号:
10452114
负责人:
Zhixun Dou
金额:
$25.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2024-03-31
关键词:
AddressAgeAgingAutomobile DrivingAutophagocytosisBindingBiochemicalBullaCell AgingCell Cycle ArrestCell NucleusCellsChromatinChronicComputer AnalysisCoupledCytoplasmCytoplasmic OrganelleCytoplasmic VesiclesCytosolDNADNA BindingDNA sequencingDevelopmentDiseaseEpigenetic ProcessExhibitsFormaldehydeGene ExpressionGenesGeneticGenomeGenomic DNAGenomic SegmentGrowth FactorImageImmuneImmunoprecipitationInfectionInflammationInflammatoryInflammatory ResponseKnowledgeLaboratoriesLongevityLysosomesMediatingMembraneMusMutationNatural ImmunityNatureNuclear EnvelopeOutcomePathway interactionsPeptide HydrolasesPharmacologic SubstancePhenotypeProcessResearchSamplingSignal TransductionSourceStimulator of Interferon GenesTissuesagedantimicrobialautocrinebasechemokinecrosslinkcytokinegenetic informationhealthspanhealthy agingmicrobialnext generation sequencingnovel strategiesnovel therapeuticsparacrineprogramsprotein complexrecruitsenescencetrafficking
中文摘要
项目摘要
细胞衰老是与炎症反应相关的细胞周期停滞的稳定形式。衰老
细胞积聚在老化和患病的组织中,并被认为是导致
慢性炎症,涉及大多数(如果不是全部)与年龄相关的疾病。与这一概念相一致,
衰老细胞的遗传或药物清除延长了小鼠的寿命和健康期。
衰老细胞分泌大量的促炎细胞因子、趋化因子、生长因子,
蛋白酶,统称为衰老相关分泌表型(SASP)。SASP计划
改变组织微环境并募集免疫细胞,最终导致炎症。我们组最近
结果显示,衰老细胞在细胞质中显示出基因组DNA,这被细胞解释为“危险”,
通过触发促进SASP的先天免疫细胞溶质DNA传感cGAS-STING途径,
衰老的程序这些发现已经被几个实验室独立复制,
cGAS-STING途径被认为是SASP程序的中心机制。
细胞质基因组DNA的遗传起源是衰老中一个尚未解决的问题。我们的成像
结果表明,胞质DNA来源于染色质片段,由核质介导
运输,通过核膜泡分配到细胞质中。但是基因组的哪些部分
穿梭于细胞质中这些区域的染色质状态如何?基因组会丢失基因吗?这些
问题需要无偏见的排序方法来解决。本申请提出了两种新颖的策略
对衰老细胞的细胞质DNA进行测序。首先,我们的目标是鉴定cGAS相关的胞质DNA,
衰老,通过进行cGAS DNA免疫沉淀。第二,我们的目标是生物化学压裂
来自衰老细胞的细胞质的DNA。DNA样本将进行下一代测序,
计算分析以探索染色质标记和基因表达状态。这些结果将允许
我们可以直接操纵基因组DNA,以询问细胞经历基因组改造后的功能结果。
DNA运输到细胞质。
这项研究将有助于衰老领域了解衰老的关键机制-
相关的炎症,并可能揭示以前未知的知识的遗传改变,
衰老和老化。这项研究有可能促进新的方法来靶向和抑制慢性
炎症,以促进健康衰老和抑制与年龄相关的疾病。
英文摘要
PROJECT SUMMARY
Cellular senescence is a stable form of cell cycle arrest associated with inflammatory responses. Senescent
cells accumulate in aged and diseased tissues and are considered as one of the major sources contributing to
chronic inflammation that is implicated in most, if not all, age-associated disorders. Consistent with this notion,
genetic or pharmaceutical clearance of senescent cells extend lifespan and healthspan of mice.
Senescent cells secret a large array of pro-inflammatory cytokines, chemokines, growth factors, and
proteases, collectively referred to as senescence-associated secretory phenotype (SASP). The SASP program
alters tissue microenvironment and recruits immune cells, ultimately leading to inflammation. Our group recently
showed that senescent cells exhibit genomic DNA in the cytosol, which is interpreted by the cells as a “danger
signal” by triggering the innate immunity cytosolic DNA sensing cGAS-STING pathway that promotes the SASP
program of senescence. These findings have been independently reproduced by several laboratories, and
collectively the cGAS-STING pathway is considered as a central mechanism for the SASP program.
A major unaddressed question in senescence is the genetic origin of cytosolic genomic DNA. Our imaging
results suggest that the cytosolic DNA is derived from fragments of chromatin, mediated by nucleus-to-cytoplasm
trafficking, via nuclear membrane blebs that partition into the cytoplasm. But which parts of the genome are
shuttled to the cytoplasm? What is the chromatin status of those regions? Does the genome lose genes? These
questions require unbiased sequencing approaches to address. This application proposes two novel strategies
to sequence cytoplasmic DNA in senescent cells. First, we aim to identify cGAS-associated cytosolic DNA in
senescence, by performing cGAS DNA-immunoprecipitation. Second, we aim to biochemically fractionate the
DNA from the cytoplasm of senescent cells. The DNA samples will be subjected to next-gen sequencing and
computational analyses to explore the chromatin marks and gene expression status. These results will permit
us to directly manipulate the genomic DNA to inquire the functional consequences of cells undergoing genomic
DNA trafficking to the cytoplasm.
This study will help the senescence field understand a critical mechanism underlying senescence-
associated inflammation, and may reveal previously unknown knowledge of the genetic alterations of
senescence and aging. This study has the potential to facilitate new approaches to target and inhibit chronic
inflammation to promote healthy aging and to suppress age-associated diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nucleus-to-cytoplasm trafficking of chromatin fragments in senescence and aging
-
批准号:10722474
-
项目类别:
-
资助金额:$55.71万
-
财政年份:2023
-
负责人:Zhixun Dou
-
依托单位:
Exploring the sequence identity of cytoplasmic chromatin in senescence
-
批准号:10629244
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2022
-
负责人:Zhixun Dou
-
依托单位:
Single-cell proteomic identification of novel markers of senescence
-
批准号:10907052
-
项目类别:
-
资助金额:$90.18万
-
财政年份:2021
-
负责人:Zhixun Dou
-
依托单位:
Single-cell proteomic identification of novel markers of senescence
-
批准号:10376580
-
项目类别:
-
资助金额:$58.8万
-
财政年份:2021
-
负责人:Zhixun Dou
-
依托单位:
Single-cell proteomic identification of novel markers of senescence
-
批准号:10818822
-
项目类别:
-
资助金额:$10.86万
-
财政年份:2021
-
负责人:Zhixun Dou
-
依托单位:
Autophagy degradation of nuclear and chromatin constituents
-
批准号:10026756
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Zhixun Dou
-
依托单位:
Autophagy degradation of nuclear and chromatin constituents
-
批准号:10408753
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Zhixun Dou
-
依托单位:
Autophagy degradation of nuclear and chromatin constituents
-
批准号:10649629
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Zhixun Dou
-
依托单位:
Autophagy-mediated chromatin degeneration in aging and age-related diseases
-
批准号:9791148
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2018
-
负责人:Zhixun Dou
-
依托单位:
Autophagy-mediated chromatin degeneration in aging and age-related diseases
-
批准号:9314111
-
项目类别:
-
资助金额:$11.07万
-
财政年份:2017
-
负责人:Zhixun Dou
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: